Skip to main content
OpenTrials

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

204 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Enrolling by invitation

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

NCT07338968

Conditions
Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +13 more
Locations
  • Retinal Consultants Medical Group, Inc. Sacramento, California, United States
  • W.K. Kellogg Eye Center - University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Retina Consultants of Oklahoma Oklahoma City, Oklahoma, United States
View Trial Details
Active, not recruiting

A Prospective Natural History Study in Uveal Melanoma

NCT04588662

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 17 locations
View Trial Details
Active, not recruiting

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

NCT01979523

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Active, not recruiting

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

NCT06007690

Conditions
Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +14 more
Locations
  • UCSD Shiley Eye Institute, Jacobs Retina Center La Jolla, California, United States
  • Doris Stein Eye Research Center Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • Retinal Consultants Medical Group, Inc. Sacramento, California, United States
View all 66 locations
View Trial Details
Active, not recruiting

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

NCT05415072

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Memorial Sloane Ketterin Cancer Ctr New York, United States
  • Novartis Investigative Site Westmead, New South Wales, Australia
View Trial Details
Active, not recruiting

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

NCT04130516

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
View Trial Details

Related conditions